Chiron Reports Profit, But So What?
128103
Considering the debacle with the flu vaccine, Chiron&#39;s (Nasdaq: CHIR) earnings release announcing that it beat analyst expectations is more than somewhat superfluous.
432305
When was the last time you heard about a company more than doubling its profit from the previous year, but an error in judgment restrained that profit?
42111
By Darin Fenger, The Sun, Yuma, Ariz.  Mar. 5--There's profit in poo.   Just ask a local organic fertilizer dealer like Dugan LaRose, a fellow who can testify that it all sure does stink, but it sure is the smell of success.
208768
Chiron Corp. CHIR.O mistakenly  reported in a regulatory filing that it received a U.S. House  of Representatives committee subpoena for certain records  relating to its flu vaccine, the company said on Monday.
567677
Chiron Corp. may begin ramping up for flu vaccine production before British and U.S. regulators have officially re-approved its manufacturing license, under a plan disclosed by Chief Executive Howard Pien on ...
572024
Pernod Ricard, the liquor maker, said its annual profit rose less than forecast as a result of higher spending on advertising. Profit for the year ended June 30, excluding interest, taxes and amortization, was 1.26 billion euros ($1.6 billion), missing some analystsÂ estimates. Net income rose 32 percent, to 639 million euros. The results are the first full-year numbers since Pernod bought Allied Domecq for $13 billion last year. Pernod, which is based in Paris, said it increased its marketing spending during the year to 1.04 billion euros from 593 million a year earlier.
704721
Growing profits isn't magic. It's math.
204455
A few thoughts on the earnings warning.
139290
Biogen Idec Inc., the third-biggest US biotechnology company, reported a fourth-quarter profit of $48.4 million, helped by sales of its Avonex and Tysabri multiple-sclerosis treatments. Net income was 14 cents a share compared with a net loss of $990.6 million, or $4.03, a year earlier, the Cambridge company said. Revenue almost doubled to $586 million. Biogen is counting on Tysabri, ...
757185
YESTERDAY Close $23.88 Change +$0.26 52-WEEK High $25.72 Low $16.97 Cubist Pharmaceuticals Inc. said third-quarter profit surged on a 52 percent increase in sales of the antibiotic Cubicin.
113641
Chiron Corp. CHIR.O on Tuesday  slashed its 2004 earnings forecast after announcing that it  will not record any sales of its flu vaccine for the 2004-2005  flu season, sending its shares down 18 percent.
696412
Profits abound, but free cash flow goes missing.
91460
The Chinese earnings reports are coming. The Chinese earnings reports are coming.
675318
EchoStar (DISH:Nasdaq - news - research) posted a third-quarter profit and declared a one-time $1 dividend Tuesday. The direct satellite broadcaster said the dividend would total $455 million and be payable on Dec. 14 to shareholders of record Dec. 8.
558157
It's on track to meet sales targets, but profits might not keep pace.
606485
Plus: HP profit gains on cost cuts, cheaper components...Dell execs skewed numbers to meet earnings targets...Applied Materials posts lower quarterly profit.
602174
The money is coming. Profit from where it will go.